# Law No. 3820 of November 11, 1960

> Brazilian law

**Wikidata**: [Q105648786](https://www.wikidata.org/wiki/Q105648786)  
**Source**: https://4ort.xyz/entity/law-no-3820-of-november-11-1960

## Summary
Law No. 3820 of November 11, 1960, is a Brazilian statute that established the Federal Council of Pharmacy and Regional Pharmacy Councils, regulating the pharmaceutical profession. Enacted during the government of President Juscelino Kubitschek, it defined the legal framework for pharmacy practice, membership requirements, and ethical standards. This law remains a foundational text for pharmaceutical regulation in Brazil.

## Key Facts
- **Enactment Date:** November 11, 1960.
- **Approved By:** Presidency of the Federative Republic of Brazil (Juscelino Kubitschek).
- **Jurisdiction:** Federative Republic of Brazil.
- **Legal Citation:** Lei nº 3820/1960.
- **Primary Purpose:** Creation of the Federal Council of Pharmacy and Regional Pharmacy Councils.
- **Key Provisions:** Regulation of pharmaceutical practice, membership criteria, fee structures, and professional ethics.
- **Language:** Brazilian Portuguese.
- **Publication Details:** Published in Brasília on November 11, 1960.
- **Identifier:** lexml_brazil_id: `urn:lex:br:federal:lei:1960-11-11;3820`.
- **Related Concepts:** Professional regulation, pharmacy practice, public health, and ethics.
- **Focus Areas:** Competency standards, registration requirements, disciplinary procedures, and fee obligations.

## FAQs
**What is the main purpose of Law No. 3820?**  
This law established the Federal Council of Pharmacy and Regional Pharmacy Councils in Brazil, creating a regulatory framework for the pharmaceutical profession, including licensing, ethics, and practice standards.

**Who enacted Law No. 3820?**  
The law was approved by President Juscelino Kubitschek on November 11, 1960, as part of Brazil’s statutory legal system.

**What key topics does the law address?**  
It covers professional registration, competency requirements, fee structures, disciplinary actions, and ethical obligations for pharmacists, ensuring standardized practice across Brazil.

**Is the law still in effect?**  
While the law remains a foundational text, subsequent amendments and regulations (e.g., Law No. 9.295/1996) have updated aspects of pharmaceutical practice in Brazil.

**Where can the full text be accessed?**  
The law is publicly available via the Brazilian Government’s legal database at [https://www.planalto.gov.br/ccivil_03/leis/l3820.htm](https://www.planalto.gov.br/ccivil_03/leis/l3820.htm).

## Why It Matters
Law No. 3820 is pivotal in Brazilian healthcare history, as it institutionalized the regulation of pharmacy practice, ensuring public safety and professional accountability. By establishing the Federal and Regional Pharmacy Councils, it created a structured system for licensing, ethics enforcement, and continuing education, which has evolved to meet modern pharmaceutical challenges. This law underpins Brazil’s capacity to oversee medicinal products, respond to health crises, and integrate with global pharmaceutical standards, directly impacting public health outcomes and professional integrity.

## Notable For
- **Foundational Regulation:** First comprehensive legislation governing pharmacy practice in Brazil.
- **Institutional Creation:** Established the Federal Council of Pharmacy and Regional Councils, which remain critical to healthcare governance.
- **Ethical Standards:** Introduced binding ethical codes for pharmacists, emphasizing patient safety and professional conduct.
- **Public Health Impact:** Strengthened oversight of pharmaceutical services, influencing drug quality and accessibility nationwide.
- **Enduring Framework:** Served as the basis for subsequent regulatory updates, ensuring continuity in professional standards.

## Body

### Historical Context
Enacted on November 11, 1960, during the administration of President Juscelino Kubitschek, Law No. 3820 responded to growing demands for standardized pharmaceutical practices in Brazil. The mid-20th century saw rapid urbanization and advancements in medical science, necessitating rigorous regulation of pharmacists to protect public health. This law marked a shift from fragmented regional practices to a unified national system.

### Legal Provisions
The statute’s key provisions include:  
- **Institutional Structure:** Creation of the Federal Council of Pharmacy (Conselho Federal de Farmácia) and Regional Pharmacy Councils (Conselhos Regionais de Farmácia), tasked with overseeing professional conduct.  
- **Registration Mandates:** Mandatory registration for all practicing pharmacists, with criteria for education, training, and ethical compliance.  
- **Fee Regulations:** Standardized fee structures for services and council operations.  
- **Disciplinary Measures:** Procedures for addressing professional misconduct, including sanctions and appeals processes.  
- **Ethical Guidelines:** Emphasis on patient safety, confidentiality, and adherence to medical protocols.  

### Regulatory Impact
Law No. 3820 centralized pharmaceutical regulation under the Federal Council, which today operates under the Ministry of Health. The councils enforce compliance with legal norms, certify professionals, and update standards to reflect scientific advancements. This framework has adapted to contemporary challenges, such as regulating access to controlled substances and addressing pharmaceutical fraud.

### Amendments and Evolution
While Law No. 3820 remains foundational, subsequent legislation has modernized its provisions. For example:  
- **Law No. 9.295/1996:** Revised registration requirements and expanded the scope of pharmaceutical practice.  
- **Decree No. 8.575/2015:** Updated ethical guidelines to address emerging issues like digital health records and telepharmacy.  
These amendments reflect Brazil’s commitment to maintaining a responsive regulatory system rooted in the principles established in 1960.

### Professional and Public Health Significance
By standardizing pharmaceutical education, licensing, and ethics, Law No. 3820 elevated the profession’s credibility and ensured alignment with international norms. This has direct implications for public health, as regulated pharmacies are critical to:  
- **Drug Safety:** Preventing the distribution of counterfeit or substandard medications.  
- **Health Equity:** Ensuring access to essential medicines across Brazil’s diverse regions.  
- **Crisis Response:** Coordinating pharmaceutical responses during epidemics, such as the COVID-19 pandemic.  

### Institutional Legacy
The Federal Council of Pharmacy and its regional bodies continue to play a vital role in:  
- **Accreditation:** Overseeing 300+ pharmacy programs at Brazilian universities.  
- **Disciplinary Oversight:** Investigating approximately 500 misconduct cases annually.  
- **Policy Advocacy:** Advising lawmakers on pharmaceutical legislation, such as drug pricing and intellectual property rights.  

### Comparative Context
Law No. 3820 parallels global efforts to professionalize pharmacy practice, such as the UK’s Pharmacy Act 1968 and the U.S. state-level boards of pharmacy. However, Brazil’s model is distinct in its integration of federal and regional councils, reflecting the country’s federative structure and geographic challenges.

### Access and Transparency
The law’s publication in Brasília and digital availability via the Brazilian Government’s portal ensure public access to regulatory standards. This transparency supports accountability, enabling citizens and professionals to review obligations and rights under the law. As a public domain document, it aligns with Brazil’s open government initiatives, fostering trust in healthcare institutions.

## References

1. [Source](https://www.lexml.gov.br/urn/urn:lex:br:federal:lei:1960-11-11;3820)
2. [Source](https://legislacao.presidencia.gov.br/atos?tipo=LEI&numero=3820&ano=1960&data=11/11/1960&ato=65dATU650dVRVT9dc)
3. LexML Brasil